[Discovery and neuroprotective mechanisms of serofendic acid derived from fetal tissues].
Kume
Toshiaki
T
tkume@pharm.kyoto-u.ac.jp
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D053148:Caspase 3 / Q000378:metabolism; D002417:Cattle; D004224:Diterpenes / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D015195:Drug Design; D005333:Fetus / Q000737:chemistry*; D005609:Free Radicals / Q000037:antagonists & inhibitors; D018698:Glutamic Acid / Q000633:toxicity; D006801:Humans; D008928:Mitochondria; D019636:Neurodegenerative Diseases / Q000188:drug therapy; D009474:Neurons; D018696:Neuroprotective Agents; D051381:Rats
D004224:Diterpenes; D005609:Free Radicals; D018696:Neuroprotective Agents; C452642:serofendic acid; D018698:Glutamic Acid; D053148:Caspase 3